Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bicara Therapeutics
Biotech
Former Legend CEO lands at K2—Chutes & Ladders
Former Legend CEO lands at K2. VIB-spin off Tanai appoints new CEO. Transition at Bicara ahead of phase 2/3.
Donavyn Coffey
,
Marissa Russo
,
Will Maddox
Aug 14, 2026 8:30am
AC Immune CEO bids adieu—Chutes & Ladders
May 15, 2026 8:30am
Bicara CEO: ASCO data resonate more with 'people that matter'
Jun 2, 2025 4:26pm
ASCO: Chasing Merus, Bicara shares 2-year HNSCC survival data
Jun 1, 2025 3:36pm
'One of the lucky few': Bicara CEO on last year's $326M IPO
Apr 14, 2025 3:59pm
Biocon accused of IP theft to create cancer biotech Bicara
Oct 24, 2024 11:04am